Glaxosmithkline Share News (GSK)

LONDON BROKER RATINGS: Citi likes Haleon, resumes GSK at 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

LONDON BRIEFING: Ocado shares slip as loss grows; S4 shares drop 44%

(Alliance News) - Online grocer Ocado on Thursday reported an interim revenue decline and widened loss, which it put down to a UK grocery market that "contracted post pandemic and the rising cost of living crisis in UK".

Citi starts GSK spinoff Haleon at 'buy'

(Sharecast News) - Citi initiated coverage of Haleon - GlaxoSmithKline's consumer health spinoff - on Thursday with a 'buy' rating and 360p price target.

UK earnings, trading statements calendar - next 7 days

LONDON BROKER RATINGS: Goldman likes Haleon but says sell Schroders

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

LONDON MARKET CLOSE: Stocks rise on Nord Stream 1 restart report

(Alliance News) - Stocks in London ended higher on Tuesday amid hopes of a restart of natural gas supplies after months of brinkmanship by Russia over the flow to Germany and the rest of Europe.

As COVID patent war rages on, pharma group seeks fairer future access

LONDON, July 19 (Reuters) - An alliance of companies has pledged to ensure equitable access to vaccines and treatments for pandemics, as the friction around intellectual property rights for COVID-19 interventions between the pharmaceutical industry and developing nations endures.

Commodities lead FTSE 100 higher, GSK spin-off Haleon flops on debut

July 18 (Reuters) - Britain's FTSE 100 rose on Monday lifted by commodity stocks and an upbeat global mood, while shares of Haleon, spun off from drugmaker GSK, fell on their debut on the London Stock Exchange.

LONDON MARKET CLOSE: Stocks rise as historic US Fed hike fears ease

(Alliance News) - Stocks in London ended higher on Monday as investors reversed bets over a 100 basis points interest rate increase from the US Federal Reserve.

GSK's consumer arm Haleon debuts with lacklustre valuation

LONDON, July 18 (Reuters) - British drugmaker GSK spun off its consumer health business on Monday in the biggest listing in Europe for more than a decade, but the unit's market value of 30.5 billion pounds fell well short of the price rival Unilever offered to pay earlier this year.

LONDON MARKET MIDDAY: Dollar feels heat as Fed rate expectations cool

(Alliance News) - Stocks in Europe were solidly higher midday Monday, as easing US rate hike expectations boosted risk appetite, taking some steam out of a rampant dollar.

GSK spins off consumer healthcare giant Haleon

(Sharecast News) - GSK has spun off its consumer healthcare arm Haleon in Europe's largest listing for more than a decade.

TOP NEWS SUMMARY: GSK spinoff Haleon starts life as public company

(Alliance News) - The following is a summary of top news stories Monday.

TOP NEWS: GSK completes demerger of healthcare product business

(Alliance News) - GSK PLC on Monday confirmed it has completed the demerger of consumer healthcare business as Haleon PLC.

LONDON MARKET PRE-OPEN: Euromoney takeover; Deliveroo cuts outlook

(Alliance News) - Stock prices in London are seen opening higher on Monday, as Europe looks ahead to a key week on the political, monetary policy and energy market fronts.